| Product Code: ETC6736563 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
China import shipments of apremilast in 2024 saw major contributions from top exporters such as the USA, India, Japan, Germany, and Belgium. Despite the low concentration in the Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) from 2020 to 2024 experienced a decline of -7.29%. Furthermore, the growth rate from 2023 to 2024 showed a significant decrease of -13.39%, indicating a challenging market environment for apremilast imports in China.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Apremilast Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Apremilast Market Revenues & Volume, 2021 & 2031F |
3.3 China Apremilast Market - Industry Life Cycle |
3.4 China Apremilast Market - Porter's Five Forces |
3.5 China Apremilast Market Revenues & Volume Share, By Strength, 2021 & 2031F |
3.6 China Apremilast Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 China Apremilast Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 China Apremilast Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 China Apremilast Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.10 China Apremilast Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 China Apremilast Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 China Apremilast Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of skin diseases such as psoriasis in China |
4.2.2 Increasing awareness about the benefits of apremilast for treating skin conditions |
4.2.3 Favorable government initiatives promoting healthcare access and affordability |
4.3 Market Restraints |
4.3.1 High cost associated with apremilast treatment |
4.3.2 Stringent regulatory requirements for drug approval in China |
5 China Apremilast Market Trends |
6 China Apremilast Market, By Types |
6.1 China Apremilast Market, By Strength |
6.1.1 Overview and Analysis |
6.1.2 China Apremilast Market Revenues & Volume, By Strength, 2021- 2031F |
6.1.3 China Apremilast Market Revenues & Volume, By 10mg, 2021- 2031F |
6.1.4 China Apremilast Market Revenues & Volume, By 20mg, 2021- 2031F |
6.1.5 China Apremilast Market Revenues & Volume, By 30mg, 2021- 2031F |
6.2 China Apremilast Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 China Apremilast Market Revenues & Volume, By Antirheumatics, 2021- 2031F |
6.2.3 China Apremilast Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Apremilast Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 China Apremilast Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 China Apremilast Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 China Apremilast Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 China Apremilast Market Revenues & Volume, By Psoriasis, 2021- 2031F |
6.4.3 China Apremilast Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.4.4 China Apremilast Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Apremilast Market, By Dosage Form |
6.5.1 Overview and Analysis |
6.5.2 China Apremilast Market Revenues & Volume, By Tablet, 2021- 2031F |
6.5.3 China Apremilast Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Apremilast Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 China Apremilast Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 China Apremilast Market Revenues & Volume, By Others, 2021- 2031F |
6.7 China Apremilast Market, By End-Users |
6.7.1 Overview and Analysis |
6.7.2 China Apremilast Market Revenues & Volume, By Clinic, 2021- 2031F |
6.7.3 China Apremilast Market Revenues & Volume, By Hospital, 2021- 2031F |
6.7.4 China Apremilast Market Revenues & Volume, By , 2021- 2031F |
6.8 China Apremilast Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 China Apremilast Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.8.3 China Apremilast Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.8.4 China Apremilast Market Revenues & Volume, By , 2021- 2031F |
7 China Apremilast Market Import-Export Trade Statistics |
7.1 China Apremilast Market Export to Major Countries |
7.2 China Apremilast Market Imports from Major Countries |
8 China Apremilast Market Key Performance Indicators |
8.1 Number of dermatology clinics offering apremilast treatment |
8.2 Patient satisfaction rates with apremilast therapy |
8.3 Rate of adoption of apremilast by healthcare providers |
9 China Apremilast Market - Opportunity Assessment |
9.1 China Apremilast Market Opportunity Assessment, By Strength, 2021 & 2031F |
9.2 China Apremilast Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 China Apremilast Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 China Apremilast Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 China Apremilast Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.6 China Apremilast Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 China Apremilast Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 China Apremilast Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Apremilast Market - Competitive Landscape |
10.1 China Apremilast Market Revenue Share, By Companies, 2024 |
10.2 China Apremilast Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here